Diagnostyka S.A. DIA.WA

Healthcare · Diagnostics & Research · valued as of 2026-11-03 · statements 2025-12-31

Average Intrinsic Value
$946.52M
Market Cap
$1.37B
Margin of Safety
-44.6%
Intrinsic / Market Ratio
0.69

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

718.70M USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

1.67B USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

455.21M USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

946.52M USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

946.52M USD

from the sum above

Market Cap

1.37B USD

today's price times the shares

Intrinsic Value ÷ Market Cap

0.69×

the ratio the screener ranks by; Margin of Safety -44.6% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 718.70M USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)918.08M USD
−②Net Debt Today321.05M USD
+③Growth Value121.66M USD
=Value718.70M USD

EPV of the Operations (NOPAT over WACC)

918.08M USD

Net debt today

-321.05M USD

Growth Value

+121.66M USD

Value

718.70M USD

①EPV (earnings power value)

918.08M USD

②Net Debt Today

321.05M USD

③Growth Value

121.66M USD

Market value

Market Cap1.37B USD

Today's price times the shares.

Value vs market

Margin of Safety-90.4%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 1.67B USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE1.34B USD
+②Equity at Year 15, Today324.10M USD
=Value1.67B USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROE on new investment falling to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

1.34B USD

②Equity at Year 15, Today

324.10M USD

Market value

Market Cap1.37B USD

Today's price times the shares.

Value vs market

Margin of Safety+17.8%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 455.21M USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).
①Present Value of the 15 Years of FCFF629.93M USD
+②Invested Capital at Year 15, Today146.33M USD
−③Net Debt Today321.05M USD
=Value455.21M USD
FCFF: the NOPAT left for the shareholders and the lenders once the business reinvests what next year's growth needsReinvestment: the part of the year's NOPAT put back into the business to grow the next year; below zero, capital the business releasesPresent value of the FCFFColoured bars show the FCFF, grey bars the reinvestment. With a positive reinvestment the two stacked are the year's NOPAT; with a negative one the grey is below zero, capital the business releases, and the NOPAT is the FCFF plus that negative amount. Shaded, years 6 to 10: the growth rising to its long-run rate and the ROIC on new investment falling to the WACC. Axes linear.

①Present Value of the 15 Years of FCFF

629.93M USD

②Invested Capital at Year 15, Today

146.33M USD

③Net Debt Today

321.05M USD

Market value

Market Cap1.37B USD

Today's price times the shares.

Value vs market

Margin of Safety-200.6%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 9.42%
weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.
Cost of Equity =Risk-Free Rate 4.50%+Beta (default) 1.00×Market Risk Premium 6.00%= 10.50%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 15.33M USDPretax Income 88.31M USD= 17.36%

The tax the interest saves.

Interest Expense =EBIT 107.50M USD−Pretax Income 88.31M USD= 19.19M USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 19.19M USDTotal Debt 325.73M USD×(1 − Tax Rate for WACC 17.36%)= 4.87%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 325.73M USDMarket Cap + Total Debt 1.37B USD + 325.73M USD= 19.23%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 80.77%×Cost of Equity 10.50%+Debt Weight 19.23%×Cost of Debt 4.87%= 9.42%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-06-30.

Total Assets 595.16M USD − Total Liabilities 454.54M USD = Book Value Today 140.62M USD

Total Debt 325.73M USD − Cash and Short-Term Investments 4.68M USD = Net Debt Today 321.05M USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 10.0%at most 5%passes33,756,500 / 33,756,500
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets14.1%at least -10.0%passes(153.77M USD − 70.12M USD) ÷ 595.16M USD
Price to bookMarket Cap ÷ Book Value Today9.73×at most 3×does not pass1.37B USD ÷ 140.62M USD
Operating marginOperating Income ÷ Revenue15.9%above 10.0%passes106.92M USD ÷ 671.77M USD
Revenue growthRevenue ÷ Revenue a Year Before − 141.3%above 10.0%passes671.77M USD / 475.30M USD
Net cash(Cash − Total Debt) ÷ Market Cap-23.5%above -30%passes(4.68M USD − 325.73M USD) ÷ 1.37B USD
Operating efficiencyOperating Income ÷ Gross Profit20.1%above 25.0%does not pass106.92M USD ÷ 531.03M USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Market data
The data provider's own ratios and the analysts' consensus, read beside the valuation, never in it.

Share price

159 USD

Enterprise value

6.60B USD

market cap plus net debt

EV / EBITDA

10.87×

Price / book

10.53×

the provider's book

Price / earnings

21.06×

Return on equity

55.4%

the provider's, not the engine's

Profit margin

9.9%

Revenue growth

16.1%

Analyst target, mean

197 USD

Analysts

7

opinions in the consensus

Financial Statements

The income statement, the balance sheet and the cash flow the screener holds, year by year, in USD.

Financial statements, year by year
The annual lines the screener holds today, in USD at each period's rate; the figures this valuation read are in its calculation above.
USD2022202320242025
Income statement

Revenue

327.74M405.96M475.30M671.77M

Gross profit

213.58M264.20M372.94M531.03M

Operating income

57.54M59.68M82.20M106.92M

EBITDA

operating income before depreciation and amortisation

86.87M95.88M124.32M163.74M

Pretax income

50.65M44.38M70.97M88.31M

Net income

38.22M31.55M54.43M70.12M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

38.16M32.94M54.28M70.34M

R&D

————
Balance sheet, year end

Total assets

273.17M357.43M418.73M576.76M

Total liabilities

200.53M271.57M313.07M424.26M

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

71.35M83.12M102.03M147.26M

Total debt

164.49M217.43M236.27M301.17M

Cash and equivalents

20.77M24.25M9.88M5.13M

Net PP&E

fixed assets after depreciation

128.03M160.20M193.07M271.33M

Working capital

current assets less current liabilities

8.00M2.59M-16.82M-38.48M
Cash flow

Operating cash flow

64.81M85.89M101.25M153.77M

Capital expenditure

paid out, so below zero

-20.40M-20.79M-32.34M-57.07M

Depreciation and amortisation

28.73M37.64M39.37M56.24M

Free cash flow

operating cash flow plus capital expenditure

44.41M65.10M68.91M96.70M